News stories about Concord Medical Services (NYSE:CCM) have trended positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Concord Medical Services earned a coverage optimism score of 0.36 on Accern’s scale. Accern also gave headlines about the company an impact score of 48.8874950986114 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Shares of Concord Medical Services (CCM) traded down $0.07 on Friday, hitting $2.58. The stock had a trading volume of 1,814 shares, compared to its average volume of 9,741. The company has a quick ratio of 1.59, a current ratio of 1.60 and a debt-to-equity ratio of 0.20. The stock has a market cap of $111.88, a PE ratio of -2.26 and a beta of 0.72. Concord Medical Services has a fifty-two week low of $2.46 and a fifty-two week high of $4.96.
WARNING: This article was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://sportsperspectives.com/2018/02/17/concord-medical-services-ccm-given-daily-news-impact-score-of-0-36.html.
Concord Medical Services Company Profile
Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China.
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.